These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

622 related articles for article (PubMed ID: 26651926)

  • 21. PBOV1 as a potential biomarker for more advanced prostate cancer based on protein and digital histomorphometric analysis.
    Carleton NM; Zhu G; Gorbounov M; Miller MC; Pienta KJ; Resar LMS; Veltri RW
    Prostate; 2018 May; 78(7):547-559. PubMed ID: 29520928
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prostate specific G protein coupled receptor is associated with prostate cancer prognosis and affects cancer cell proliferation and invasion.
    Cao W; Li F; Yao J; Yu J
    BMC Cancer; 2015 Nov; 15():915. PubMed ID: 26582057
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Activation of the Y1 receptor by neuropeptide Y regulates the growth of prostate cancer cells.
    Ruscica M; Dozio E; Boghossian S; Bovo G; Martos Riaño V; Motta M; Magni P
    Endocrinology; 2006 Mar; 147(3):1466-73. PubMed ID: 16339211
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identification of candidate diagnostic and prognostic biomarkers for human prostate cancer: RPL22L1 and RPS21.
    Liang Z; Mou Q; Pan Z; Zhang Q; Gao G; Cao Y; Gao Z; Pan Z; Feng W
    Med Oncol; 2019 May; 36(6):56. PubMed ID: 31089825
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Expression patterns of candidate susceptibility genes HNF1β and CtBP2 in prostate cancer: association with tumor progression.
    Debiais-Delpech C; Godet J; Pedretti N; Bernard FX; Irani J; Cathelineau X; Cussenot O; Fromont G
    Urol Oncol; 2014 May; 32(4):426-32. PubMed ID: 24332637
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Differential tissue expression of extracellular vesicle-derived proteins in prostate cancer.
    Duijvesz D; Rodriguez-Blanco G; Hoogland AM; Verhoef EI; Dekker LJ; Roobol MJ; van Leenders GJLH; Luider TM; Jenster G
    Prostate; 2019 Jun; 79(9):1032-1042. PubMed ID: 31018022
    [TBL] [Abstract][Full Text] [Related]  

  • 27. ERG protein expression in diagnostic specimens is associated with increased risk of progression during active surveillance for prostate cancer.
    Berg KD; Vainer B; Thomsen FB; Røder MA; Gerds TA; Toft BG; Brasso K; Iversen P
    Eur Urol; 2014 Nov; 66(5):851-60. PubMed ID: 24630684
    [TBL] [Abstract][Full Text] [Related]  

  • 28. βIII-tubulin overexpression is an independent predictor of prostate cancer progression tightly linked to ERG fusion status and PTEN deletion.
    Tsourlakis MC; Weigand P; Grupp K; Kluth M; Steurer S; Schlomm T; Graefen M; Huland H; Salomon G; Steuber T; Wilczak W; Sirma H; Simon R; Sauter G; Minner S; Quaas A
    Am J Pathol; 2014 Mar; 184(3):609-17. PubMed ID: 24378408
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tissue Proteome Signatures Associated with Five Grades of Prostate Cancer and Benign Prostatic Hyperplasia.
    Kawahara R; Recuero S; Nogueira FCS; Domont GB; Leite KRM; Srougi M; Thaysen-Andersen M; Palmisano G
    Proteomics; 2019 Nov; 19(21-22):e1900174. PubMed ID: 31576646
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The expression profile and prognostic value of SPINK1 in initially diagnosed bone metastatic prostate cancer.
    Pan X; Zhang X; Gong J; Tan J; Yin X; Tang Q; Shu K; Shen P; Zeng H; Chen N
    Prostate; 2016 Jun; 76(9):823-33. PubMed ID: 27159572
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tissue metabolite profiling identifies differentiating and prognostic biomarkers for prostate carcinoma.
    Jung K; Reszka R; Kamlage B; Bethan B; Stephan C; Lein M; Kristiansen G
    Int J Cancer; 2013 Dec; 133(12):2914-24. PubMed ID: 23737455
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Proteomic analysis of formalin-fixed prostate cancer tissue.
    Hood BL; Darfler MM; Guiel TG; Furusato B; Lucas DA; Ringeisen BR; Sesterhenn IA; Conrads TP; Veenstra TD; Krizman DB
    Mol Cell Proteomics; 2005 Nov; 4(11):1741-53. PubMed ID: 16091476
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Proteomic Characterization of Prostate Cancer to Distinguish Nonmetastasizing and Metastasizing Primary Tumors and Lymph Node Metastases.
    Müller AK; Föll M; Heckelmann B; Kiefer S; Werner M; Schilling O; Biniossek ML; Jilg CA; Drendel V
    Neoplasia; 2018 Feb; 20(2):140-151. PubMed ID: 29248718
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Expression of ERG protein, a prostate cancer specific marker, in high grade prostatic intraepithelial neoplasia (HGPIN): lack of utility to stratify cancer risks associated with HGPIN.
    He H; Osunkoya AO; Carver P; Falzarano S; Klein E; Magi-Galluzzi C; Zhou M
    BJU Int; 2012 Dec; 110(11 Pt B):E751-5. PubMed ID: 23046279
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Decreased RECK expression indicating proteolytic imbalance in prostate cancer is associated with higher tumor aggressiveness and risk of prostate-specific antigen relapse after radical prostatectomy.
    Rabien A; Burkhardt M; Jung M; Fritzsche F; Ringsdorf M; Schicktanz H; Loening SA; Kristiansen G; Jung K
    Eur Urol; 2007 May; 51(5):1259-66. PubMed ID: 16806661
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Zonal regulation of collagen-type proteins and posttranslational modifications in prostatic benign and cancer tissues by imaging mass spectrometry.
    Angel PM; Spruill L; Jefferson M; Bethard JR; Ball LE; Hughes-Halbert C; Drake RR
    Prostate; 2020 Sep; 80(13):1071-1086. PubMed ID: 32687633
    [TBL] [Abstract][Full Text] [Related]  

  • 37. ERG expression in prostate cancer: the prognostic paradox.
    Taris M; Irani J; Blanchet P; Multigner L; Cathelineau X; Fromont G
    Prostate; 2014 Nov; 74(15):1481-7. PubMed ID: 25175352
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Heterogeneity of PTEN and ERG expression in prostate cancer on core needle biopsies: implications for cancer risk stratification and biomarker sampling.
    Shah RB; Bentley J; Jeffery Z; DeMarzo AM
    Hum Pathol; 2015 May; 46(5):698-706. PubMed ID: 25724568
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The prostate cancer immunome: In silico functional analysis of antigenic proteins from microarray profiling with IgG.
    Luna-Coronell JA; Vierlinger K; Gamperl M; Hofbauer J; Berger I; Weinhäusel A
    Proteomics; 2016 Apr; 16(8):1204-14. PubMed ID: 27089054
    [TBL] [Abstract][Full Text] [Related]  

  • 40. sE-cadherin serves as a diagnostic and predictive parameter in prostate cancer patients.
    Tsaur I; Thurn K; Juengel E; Gust KM; Borgmann H; Mager R; Bartsch G; Oppermann E; Ackermann H; Nelson K; Haferkamp A; Blaheta RA
    J Exp Clin Cancer Res; 2015 May; 34(1):43. PubMed ID: 25967040
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 32.